Why India Has No Plans To Depend On Pfizer For Covid-19 Vaccine
The Centre is not going to keep all its eggs in the same basket and have its own vaccine ready in time
While India is planning to support some poor countries with doses of Covid-19 vaccine, it is going to get an advantage of lesser-priced vaccine doses from the American biotech company Pfizer. Sources have confirmed that Pfizer is seeing the need to reduce its pricing to suit the Indian market. India was not planning to pick the dose from the US drug maker due to the high price and the fact that the vaccine is temperature sensitive, a tough proposition for a country like India that has varied temperatures throughout its length and breadth.
The Covid-19
vaccine has to kept under certain temperature that supports the efficacy of the
drug. The Pfizer- BioNtech developed vaccine has extreme cold chain requirement
at minus 70 degree Celsius.
Then there
are logistic and storage challenges to be faced as well. Dr. V.K. Paul at the
NITI Aayog has already stated that it is a huge challenge to store the vaccine
on such low temperatures, and that also for longer durations.
India still
has a backup plan- it has been developing its own candidate in collaboration with
other pharma companies. The controversial Russian Sputnik IV candidate maker is
also working a formula up with India. But unlike Canada, India does not be put
all its eggs in the same basket.
The centre is
keeping its options open, owing to the fact that India has a sizable population
it would need to take care of. A huge chunk cannot afford expensive vaccines and
therefore the Centre has not make arrangements for subsidized selling or free immunization.
There are 5
vaccine candidates at various trial stages in India. The local pharma companies
are showing promising results once they get a go ahead from the British medicine
regulatory board that certifies the safety of vaccine worldwide.
India could
actually have its own vaccine ready by the end of the year; but it is important
to wait and watch.
Comments
Post a Comment